Loghman Pharmaceuticals Explained

Loghman Pharmaceutical & Hygienic Co.
Type:	Public
Traded As:	TSE DLGM1 ISIN: IRO1DLGM0000
Location:	Tehran, Iran
Area Served:	Worldwide
Key People:	Khosro Davari, chief executive officer Alireza Zohrevand, Chairman
Products:	Pharmaceutical drug Ampoule, Tablet (pharmacy), Capsule (pharmacy)
Assets:	437 Billion IRR (2009)
Net Income:	44 Billion IRR (2009)
Homepage:	www.loghmanpharma.com

Loghman Pharmaceutical & Hygienic Co. (fa|شرکت دارویی و بهداشتی لقمان, Shirkat-e Darvii-ye vâ Behedashiti-ye Laqman) is an Iranian pharmaceuticals company. The company engages in the discovery, development, manufacture, and marketing of drugs in Iran.^[1]

History

Loghmans was established in 1968 as I.D.I. Pharmaceuticals. In 1979, the company changed its name to Loghman and expanded its operations.^[2]

The company has been listed on the Tehran Stock Exchange since 1997.^[3]

products

• Acetaminophen+Codeine
• Amoxicillin
• Azithromycin
• Buspirone
• Carbamazepine
• Cefalexin
• Cefazolin
• Cefepime
• Cefixime
• Ceftazidime
• Ceftriaxone
• Cefuroxime
• Cefalexin
• Diazepam
• Erythromycin
• Fluconazole
• Sodium Fluoride
• Ibuprofen
• Indomethacin
• Lorazepam
• Losartan Potassium
• Meropenem
• Methimazole
• Nortriptyline
• Phenytoin
• Sodium Fluoride
• Sorbitol
• Valsartan

Development plan

• Insulin

See also

• Health care in Iran

References

1. Web site: Stocks . https://web.archive.org/web/20121005192845/http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=36070257 . dead . October 5, 2012 .
2. Web site: شرکت دارویی بهداشتی لقمان . 2013-06-08 . dead . https://web.archive.org/web/20130708032000/http://www.loghman-med.com/en/index.php?option=com_content&task=view&id=40&Itemid=60 . 2013-07-08 .
3. Web site: Dlgm1 37,480.